Abstract:Recent studies have shown that tumor stemness has biological significance in tumorigenicity and tumor progression. However, the characteristics of TME immune infiltration in osteosarcoma mediated by the combined effects of multiple cancer stem cell-related genes remain unknown.Methods:In this study, we identified different cancer stem cell-associated subtypes in osteosarcoma based on 25 cancer stem cell-associated genes by consensus clustering analysis, and we comprehensively evaluated the association between these subtypes and immunocytes infiltration in the TME. The cancer stem cell (CSC) score was constructed to quantify the stemness of individual tumors.Results:We performed a comprehensive evaluation of 218 osteosarcoma patients based on 25 cancer stem cell-related genes. Three different cancer stem cells related subtypes were identified, which were related to different biological processes and clinical outcomes. The three subtypes have different TME cells infiltrating characteristics, and CSC Cluster A had a higher level of immunocyte infiltration compared to CSC Cluster B and C. We constructed a scoring system, called the CSC score, to assess the stemness of individual patients. Then we found that the prognosis of patients was predicted by CSC score, and patients with low CSC score had prolonged survival. Further analyses showed that low CSC score was correlated with enhanced immune infiltration. CSC score may predict the effect of immunotherapy, and patients with low CSC score may have better immune response and clinical prognosis.Conclusions:This study demonstrates that there could be three cancer stem cell-associated subtypes in osteosarcoma and that they were associated with different patient prognosis and TME immune infiltration characteristics. CSC score could be used to assess the stemness of individual patients, improve our comprehension of TME characteristics, and direct more effective immune therapy.

CD271+ Osteosarcoma Cells Display Stem-Like Properties.

CD133 Expression in Osteosarcoma and Derivation of CD133+ Cells

Identification of cancer stem cell-like cells from human epithelial ovarian carcinoma cell line

The CD24+ Cell Subset Promotes Invasion and Metastasis in Human Osteosarcoma

Epigenetic Regulation Of Cd271, A Potential Cancer Stem Cell Marker Associated With Chemoresistance And Metastatic Capacity

Osteosarcoma Stem Cells Have Active Wnt/β-catenin and Overexpress SOX2 and KLF4

Phenotypic Characterization of Drug Resistance and Tumor Initiating Cancer Stem Cells from Human Bone Tumor Osteosarcoma Cell Line Os-77

CD49b Inhibits Osteogenic Differentiation and Plays an Important Role in Osteosarcoma Progression.

Isolation and Identification of Osteosarcoma Stem-Like Cells

CD271 defines a stem cell-like population in hypopharyngeal cancer

Cisplatin-resistant Osteosarcoma Cells Possess Cancer Stem Cell Properties in a Mouse Model

CD133(+) CD44(+) Cells Mediate in the Lung Metastasis of Osteosarcoma.

Molecular Subtypes of Osteosarcoma Classified by Cancer Stem Cell Related Genes Define Immunological Cell Infiltration and Patient Survival.

Studies on the effect and mechanism of CD147 on melanoma stem cells

Identification of CD24 as a cancer stem cell marker in human nasopharyngeal carcinoma

Side Population Cells Isolated From Human Osteosarcoma Are Enriched With Tumor-Initiating Cells

Molecular signature of human bone marrow-derived mesenchymal stromal cell subsets

TREX1 Suppression Imparts Cancer-Stem-cell-like Characteristics to CD133- Osteosarcoma Cells Through the Activation of E2F4 Signaling.

CD44 Sorted Cells Have an Augmented Potential for Proliferation, Epithelial-Mesenchymal Transition, Stemness, and a Predominantly Inflammatory Cytokine and Angiogenic Secretome

Doxorubicin induces enrichment of stem-like cells in osteosarcoma by activating Notch signaling

Cd133 Expression Predicts Lung Metastasis And Poor Prognosis In Osteosarcoma Patients: A Clinical And Experimental Study